Name: WilmerHale Life Sciences Webinar: What the C-Suite Should Know About Corporate Inversions
Start: 2015-03-09
End: 2015-03-09
Location: Webinar

Corporate inversions have become a high-profile growth strategy for many life sciences companies. Inversions are not an end in themselves, but should be considered a potential tool for business development and global expansion. Business leaders need to understand how corporate inversions work in order to weigh the costs and benefits of implementation.

In this webinar, WilmerHale lawyers will discuss corporate inversions and their value to growing life sciences companies, including: the hallmarks of a successful transaction; regulatory trends and legislative responses to corporate inversions; the effect on shareholder value and business operations; and occasions where an inversion may not be the best strategy.

During the webinar, participants will have the opportunity to contribute questions online and interact with the panelists.

California and non-transitional New York CLE credit will be offered to those that participate in the live webinar.

WilmerHale Life Sciences Webinar: What the C-Suite Should Know About Corporate Inversions

WilmerHale Life Sciences Webinar: What the C-Suite Should Know About Corporate Inversions

You May Be Interested In

FIA Law & Compliance Division Conference 2024

18th Annual Flagship Conference on Economic Sanctions Enforcement and Compliance

Essentials of the European Union’s Artificial Intelligence Act

WilmerHale Life Sciences Webinar: What the C-Suite Should Know About Corporate Inversions

WilmerHale Life Sciences Webinar: What the C-Suite Should Know About Corporate Inversions

You May Be Interested In

FIA Law & Compliance Division Conference 2024

18th Annual Flagship Conference on Economic Sanctions Enforcement and Compliance

Essentials of the European Union’s Artificial Intelligence Act

Notice